Biochemistry Sixth Edition Bonus Chapter: Drug Development Copyright © 2005 by W. H. Freeman and...

82
Biochemistry Sixth Edition Bonus Chapter: Drug Development Copyright © 2005 by W. H. Freeman and Company Berg • Tymoczko • Stryer
  • date post

    19-Dec-2015
  • Category

    Documents

  • view

    274
  • download

    2

Transcript of Biochemistry Sixth Edition Bonus Chapter: Drug Development Copyright © 2005 by W. H. Freeman and...

BiochemistrySixth Edition

Bonus Chapter:Drug Development

Copyright © 2005 by W. H. Freeman and Company

Berg • Tymoczko • Stryer

Know “ADME”

• Administration - Absorption• Distribution in the body• Metabolism - Transformation• Excretion

Lipinski’s Rules

• MW should be less than 500• H-bond donors less than 5• H-bond acceptors less than 10• Partition coefficient less than 5

• Otherwise drug will have poor absorption!

From HW, mol wt = 604

Know structures of conjugates

• Glutathione (ECG) via -SH• Glucuronides from UDP-Glucuronic

• Sulfate from PAPS (A-stick 3’P, 5’PS)

Serendipity

Drugs discovered accidentally

Screening

Compare activities of large libraries of drugs. SAR structure activity

relationships

Cholesterol Lowering Drugs

Statins found by screening

Drug design for known target

Becoming more important. Once a drug is known,

variants can be screened for activity. Some HIV protease inhibitors:

Co-crystal structure of Arachidonic acid(ball and stick) and Cox-1. The TYR andARG stabilize the carboxylic acid. TheILE and the Aromatic Wall hem theArachidonic acid into the binding site.

ARG

ILE

TYR

SER

Aromatic Wall

O

O

Arachidonic Acid

ARG

ILE

TYR

SER

Aromatic Wall

Model of Aspirin (ball-and-stick) and Cox-1.The SER residue on the enzyme has attacked the aspirin, hydrolyzing theacetyl group and irreversibly inactivatingthe enzyme.

O O

O

O

O

O O

O HO

O

Enz

+

Enz

AcetylGroup

Salicylic Acid

Practical Guide to Identifying Non-Selective vs Selective Cox Inhibitors

O

O

O

O

O

N

O

O

O

O

Cl

NH

OO

O

it appears thatmost non-selective Cox inhibitors share the following lineararrangement of functional groups:

Greasy Aryl Alkyl Acidic

Indomethacin

Ibuprofen

Ketoprofen Etodolac

Med chemists can use this SARto guide the development of newer, better (hopefully) non-selective Cox inhibitors.

Practical Guide to Identifying Non-Selective vs Selective Cox Inhibitors

NN

Br

SNH2 O

O

F

F

F

O

S

O

O

O

ON

SNH2 O

O

NN

S

O

OCl

Most Cox-2 selectiveinhibitors are shaped likean arrowhead:

Greasy

Side chain(usually sulfonamideor sulfonyl)

Aryl

Polar

The SAR for non-selective Coxinhibitors is clearly different fromCox-2 selective inhibitors. Med chemistscan exploit this fact to design novel compounds.

rofecoxib valdecoxib

Like celecoxib, exceptBr is Me group etoricoxib

Analyzing Genomic Information

Known targets (Protein Kinases or 7TM receptors = GPCR) can suggest new

drugs.

Model Animals also yield targets

Knockout mice tell us about interesting genes/proteins